ABI-auditory brainstem implant

References

• Evans DGR. Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphan J Rare Dis. 2009;4:16.
   PubMed Web of Science ®Google Scholar
• Blakeley JO, Evans DG, Adler J, et al. Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2. Am J Med Genet A. 2012;158A(1):24–41.
   PubMedGoogle Scholar
• Morrow KA, Shevde LA. Merlin: the wizard requires protein stability to function as a tumor suppressor. Biochim Biophys Acta. 2012;1826(2):400–406.
   PubMed Web of Science ®Google Scholar
• Petrilli AM, Fernandez-Valle C. Role of Merlin/NF2 inactivation in tumor biology. Oncogene. 2016;35(5):537–548.
   PubMed Web of Science ®Google Scholar
• Jackson KB, Mark G, Helms J, et al. An auditory brainstem implant system. Am J Audiol. 2002;11(2):128–111.
   PubMedGoogle Scholar
• Behr R, Müller J, Shehata-Dieler W, et al. The high rate CIS auditory brainstem implant for restoration of hearing in NF-2 patients. Skull Base. 2007;17(2):91–107.
   PubMed Web of Science ®Google Scholar
• Matthies C, Brill S, Kaga K, et al. Auditory brainstem implantation improves speech recognition in neurofibromatosis type II patients. ORL J Otorhinolaryngol Relat Spec. 2013;75(5):282–295.
   PubMed Web of Science ®Google Scholar
• Polak M, Colletti L, Colletti L. Novel method of fitting of children with auditory brainstem implants. Eur Ann Otorhinolaryngol Head Neck Dis. 2018;135(6):403–409.
   PubMed Web of Science ®Google Scholar
• Colletti V, Carner M, Fiorino F, et al. Hearing restoration with auditory brainstem implant in three children with cochlear nerve aplasia. Otol Neurotol. 2002;23(5):682–693.
   PubMed Web of Science ®Google Scholar
• Colletti V, Shannon R, Carner M, et al. Outcomes in nontumor adults fitted with the auditory brainstem implant: 10 years’ experience. Otol Neurotol. 2009;30(5):614–618.
   PubMed Web of Science ®Google Scholar
• Sennaroglu L, Colletti V, Manrique M, et al. Auditory brainstem implantation in children and non-neurofibromatosis type 2 patients: a consensus statement. Otol Neurotol. 2011;32(2):187–191.
   PubMed Web of Science ®Google Scholar
• Sennaroglu L, et al. Consensus statement: long-term results of ABI in children with complex inner ear malformations and decision making between CI and ABI. Cochlear Implants Int. 2016;17(4):163–171.
   PubMedGoogle Scholar
• Colletti L, Colletti G, Mandala M, et al. The therapeutic dilemma of cochlear nerve deficiency: cochlear or brainstem implantation. Otolaryngol Head Neck Surg. 2014;151(2):308–314.
   PubMed Web of Science ®Google Scholar
• Yousef M, Mesallam TA, Garadat SN Almasaad A, et al. Audiologic outcome of cochlear implantation in children with cochlear nerve deficiency. Otol Neurotol. 2021;42(1):38–46.
   PubMed Web of Science ®Google Scholar
• US Patent: 6348070B1 and US Patent: 8634909B2.
   Google Scholar
• Shew M, Bertsch J, Camarata P, et al. Magnetic resonance imaging in a neurofibromatosis type 2 patient with a novel MRI-compatible auditory brainstem implant. J Neurol Surg Rep. 2017;78(1):e12–e14.
   PubMed Web of Science ®Google Scholar
• Colletti L, Shannon R, Colletti V. Auditory brainstem implants for neurofibromatosis type 2. Curr Opin Otolaryngol Head Nech Surg. 2012;20(5):353–357.
   PubMed Web of Science ®Google Scholar
• Behr R, Colletti V, Matthies C, et al. New outcomes with auditory brainstem implants in NF2 patients. Otol Neurotol. 2014;35(10):1844–1851.
   PubMed Web of Science ®Google Scholar
• Otto SR, House WF, Brackmann DE, et al. Auditory brain stem implant: effect of tumor size and preoperative hearing level on function. Ann Otol Rhinol Laryngol. 1990;99(10 Pt 1):789–790.
   PubMed Web of Science ®Google Scholar
• Svirsky M, Robbins AM, Kirk KI, et al. Language development in profoundly deaf children with cochlear implants. Psychol Sci. 2000;11(2):153–158.
   PubMed Web of Science ®Google Scholar
• Colletti L, Shannon RV, Colletti V. The development of auditory perception in children after auditory brainstem implantation. Audiol Neurootol. 2014;19(6):386–394.
   PubMed Web of Science ®Google Scholar
• Rajeswaran R, Kameswaran M. Auditory brainstem implantation (ABI) in children without neurofibromatosis type II (NF2): communication performance and safety after 24 months of use. Cochlear Implants Int. 2020;21(3):127–135.
   PubMedGoogle Scholar
• Behr R, Polak M, Brill S. Single implant bilateral auditory brainstem implantation (SIBIL-ABI): a new surgical approach. Current Trends in Otolaryngology and Rhinology (ISSN: 2689-7385)
   Google Scholar
• https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:31993L0042&from=DE.
   Google Scholar
• Colletti V, Shannon R, Carner M, et al. The first successful case of hearing produced by electrical stimulation of the human midbrain. Otol Neurotol. 2007;28(1):39–43.
   PubMed Web of Science ®Google Scholar
• Polak M. 2020. ABI engineering and intraoperative monitoring: MED-EL. In: Wilkinson EP, Schwartz MS, editors. Auditory brainstem implants. Thieme Medical Publishers. ISBN10: 1626238278.
   Google Scholar
• Polterauer D, Neuling M, Müller J, et al. PromBERA: a preoperative eABR: asn update. Curr Dir Biomed Eng. 2018;4(1):563–565.
   Google Scholar
• Skarzyński H, Szuchnik J, Lorens A, et al. First auditory brainstem implantation in Poland: auditory perception results over 12 months. J Laryngol Otol. 2000;114(27):44–45.
   Google Scholar
• Skarzyński H, Behr R, Lorens A, et al. Bilateral electric stimulation from auditory brainstem implants in a patient with neurofibromatosis type 2. Med Sci Monit. 2009;15(6):CS100–CS104.
   PubMed Web of Science ®Google Scholar
• Ontario Health (Quality). Auditory brainstem implantation for adults with neurofibromatosis 2 or severe inner ear abnormalities: a health technology assessment. Ont Health Technol Assess Ser. 2020;20(4):1–85.
   Google Scholar